https://www.selleckchem.com/pr....oducts/pyridostatin-
05+1.13) than their male counterparts (162.86 ± 3.30; -1.53+0.51) (p value 0.001; 0.048). In patients with good control, there was no difference between PAH SDS (-1.7) and FAH SDS (-1.5) (p value=0.37). In patients with poor control (over or under-treated) FAH SDS (-2.1) was significantly lower than PAH SDS (-1.4) (P value0.001). BP method was able to accurately predict FAH in children with classic CAH who were medically well controlled (based on 17-hydroxyprogesterone levels) but overestimated i
Like
Comment
Share
